Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...

• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.

Amyotrophic lateral sclerosis (ALS) is a widespread neurodegenerative disease caused by the loss of neurons that control movement. Although abnormal accumulation of proteins called TDP-43 ...

A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

"New therapeutic strategy to reduce neuronal death in amyotrophic lateral sclerosis." ScienceDaily. ScienceDaily, 16 November 2023. <www.sciencedaily.com / releases / 2023 / 11 / 231116141023.htm>.

July 7, 2022 Degradation of motor neurons, conceptual computer illustration. Amyotrophic lateral sclerosis, also referred to as Lou Gehrig's disease is the most common of the motor neuron diseases.

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The amyotrophic ...

Many people will never know the last time they will do certain things in life. Even though he navigates sometimes trying days ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...